Apogee Therapeutics Inc. Insider Transactions
Apogee Therapeutics Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
| Sell | 955 @ $64.99 | $62.07 K | 1,172,987 | 02/11/2026 | 02/13/2026 | ||
| Sell | 11,494 @ $62.96 | $723.66 K | 1,181,493 | 02/11/2026 | 02/13/2026 | ||
| Sell | 7,551 @ $63.73 | $481.23 K | 1,173,942 | 02/11/2026 | 02/13/2026 | ||
|
Dambkowski Carl
Chief Medical Officer |
Sell | 100 @ $67.88 | $6.79 K | 211,348 | 02/04/2026 | 02/04/2026 | |
|
Dambkowski Carl
Chief Medical Officer |
Sell | 1,299 @ $66.85 | $86.84 K | 211,448 | 02/04/2026 | 02/04/2026 | |
|
Dambkowski Carl
Chief Medical Officer |
Sell | 200 @ $68.94 | $13.79 K | 211,148 | 02/04/2026 | 02/04/2026 | |
|
Dambkowski Carl
Chief Medical Officer |
Sell | 2,481 @ $64.88 | $160.97 K | 214,167 | 02/04/2026 | 02/04/2026 | |
|
Dambkowski Carl
Chief Medical Officer |
Sell | 1,420 @ $65.83 | $93.48 K | 212,747 | 02/04/2026 | 02/04/2026 | |
|
Henderson Jane
CFO |
Sell | 792 @ $65.21 | $51.65 K | 184,579 | 02/02/2026 | 02/04/2026 | |
|
Henderson Jane
CFO |
Sell | 100 @ $66.89 | $6.69 K | 183,371 | 02/02/2026 | 02/04/2026 | |
|
Henderson Jane
CFO |
Sell | 1,108 @ $66.15 | $73.29 K | 183,471 | 02/02/2026 | 02/04/2026 | |
|
Fairmount Funds Management LLC
Director |
Sell | 1,750,000 @ $76.30 | $133.53 M | 298,647 | 01/22/2026 | 01/22/2026 | |
| Sell | 2,374 @ $81.00 | $192.29 K | 1,200,697 | 01/14/2026 | 01/16/2026 | ||
| Sell | 5,386 @ $83.16 | $447.90 K | 1,193,457 | 01/14/2026 | 01/16/2026 | ||
| Sell | 1,440 @ $78.64 | $113.24 K | 1,211,547 | 01/14/2026 | 01/16/2026 | ||
| Sell | 470 @ $83.79 | $39.38 K | 1,192,987 | 01/14/2026 | 01/16/2026 | ||
| Sell | 8,476 @ $79.82 | $676.55 K | 1,203,071 | 01/14/2026 | 01/16/2026 | ||
| Sell | 1,854 @ $82.41 | $152.79 K | 1,198,843 | 01/14/2026 | 01/16/2026 | ||
|
Dambkowski Carl
Chief Medical Officer |
Sell | 14,820 @ $77.90 | $1.15 M | 213,449 | 01/07/2026 | 01/09/2026 | |
|
Dambkowski Carl
Chief Medical Officer |
Sell | 826 @ $79.04 | $65.29 K | 212,623 | 01/07/2026 | 01/09/2026 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apogee Therapeutics Inc. FAQ's
The list of insiders at Apogee Therapeutics Inc. includes Dambkowski Carl, HENDERSON MICHAEL THOMAS, Shah Nimish P, Henderson Jane, Fairmount Funds Management LLC.
Insiders have sold a total of 1.97 M Apogee Therapeutics Inc. shares in the last 12 months for a total of 148.23 M sold.
The following insiders have sold Apogee Therapeutics Inc. shares in the last 12 months: Dambkowski Carl ($4.48 M), HENDERSON MICHAEL THOMAS ($8.96 M), Henderson Jane ($1.27 M), Fairmount Funds Management LLC ($133.53 M),
Insiders have purchased a total of 365.85 K Apogee Therapeutics Inc. shares in the last 12 months for a total of 0.
The following insiders have purchased Apogee Therapeutics Inc. shares in the last 12 months: Shah Nimish P ($0),